39.69
Schlusskurs vom Vortag:
$41.87
Offen:
$41.58
24-Stunden-Volumen:
35,225
Relative Volume:
0.08
Marktkapitalisierung:
$2.51B
Einnahmen:
$1.46B
Nettoeinkommen (Verlust:
$53.23M
KGV:
47.52
EPS:
0.8353
Netto-Cashflow:
$70.01M
1W Leistung:
-2.19%
1M Leistung:
-10.12%
6M Leistung:
+10.19%
1J Leistung:
+46.73%
Guardian Pharmacy Services Inc Stock (GRDN) Company Profile
Firmenname
Guardian Pharmacy Services Inc
Sektor
Branche
Telefon
(404) 810-0089
Adresse
300 GALLERIA PARKWAY SE, ATLANTA
Compare GRDN vs HCA, THC, EHC, FMS, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
GRDN
Guardian Pharmacy Services Inc
|
39.69 | 2.51B | 1.46B | 53.23M | 70.01M | 0.8353 |
|
HCA
Hca Healthcare Inc
|
462.49 | 100.13B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
270.50 | 21.78B | 21.46B | 2.65B | 3.35B | 19.23 |
|
EHC
Encompass Health Corp
|
120.83 | 11.92B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.60 | 11.50B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
DVA
Davita Inc
|
175.71 | 11.21B | 13.84B | 1.10B | 1.49B | 10.42 |
Guardian Pharmacy Services Inc Stock (GRDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-23 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2026-04-27 | Eingeleitet | BofA Securities | Buy |
| 2026-03-30 | Eingeleitet | Jefferies | Buy |
| 2025-10-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Outperform |
| 2024-10-21 | Eingeleitet | Truist | Buy |
Alle ansehen
Guardian Pharmacy Services Inc Aktie (GRDN) Neueste Nachrichten
Top Guardian Pharmacy Services (GRDN) Competitors 2026 - MarketBeat
What Is Behind Guardian Pharmacy Services’ (NYSE:GRDN) Stronger Results? - Kalkine Media
Transcript: Guardian Pharmacy Service Q2 2026 Earnings Conference Call - Benzinga
Guardian Pharmacy Services, Inc. (GRDN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 4 Guardian Pharmacy Services Inc For: 29 September By Investing.com - Investing.com Nigeria
Form 4 Guardian Pharmacy Services Inc For: 28 September By Investing.com - Investing.com Nigeria
Form 4 Guardian Pharmacy Services Inc For: 28 September - Investing.com India
Form 4 Guardian Pharmacy Services Inc For: 28 September By Investing.com - Investing.com South Africa
Form 4 Guardian Pharmacy Services Inc For: 28 September By Investing.com - Investing.com UK
Form 13D/A Guardian Pharmacy Services For: 28 September - Investing.com India
One-for-one share conversion at Guardian Pharmacy (GRDN) involves a director's holding company. - Stock Titan
Retirement meant forfeited stock awards for a Guardian Pharmacy (GRDN) insider, alongside a share conversion. - Stock Titan
Guardian Pharmacy converts 6.1M shares to Class A - Stock Titan
Guardian Pharmacy executive converts 641,870 shares - Stock Titan
An automatic share conversion leaves no Class B shares held by Pharmacy Investors at Guardian Pharmacy (GRDN). - Stock Titan
Guardian Pharmacy Services: Slowing Growth In H2 2026 - Seeking Alpha
Keybanc initiates coverage of Guardian Pharmacy Service with Overweight rating, $52 price target - TradingView
GUARDIAN PHARMACY SERVICES, INC. : KEYBANC INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $52 - Bitget
Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Strong Buy Ratings Signal Upside Potential - DirectorsTalk Interviews
Guardian Pharmacy Services (NYSE:GRDN) Stock Forecast & Analyst Predictions - Simply Wall Street
Truist Raises Price Target on Guardian Pharmacy Services to $51 From $47, Keeps Buy Rating - Yahoo Finance
Guardian Pharmacy Services stock hits all-time high at 47.05 USD - Investing.com Nigeria
Guardian Pharmacy Services stock hits all-time high at 47.05 USD - Investing.com
Certain Class B Common Stock of Guardian Pharmacy Services, Inc. are subject to a Lock-Up Agreement Ending on 15-SEP-2026. - marketscreener.com
Guardian Pharmacy Implements Insider Lock-Up to Support Stability - TipRanks
Most insider stock at Guardian Pharmacy Services (GRDN) is locked up into 2027 - Stock Titan
BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Maintains Target Price $47 - Moomoo
Guardian Pharmacy acquires assets from Nautilus Pharmacy - Investing.com
Guardian Pharmacy acquires assets from Nautilus Pharmacy By Investing.com - Investing.com South Africa
Guardian Pharmacy acquires assets from Nautilus Pharmacy - Investing.com India
Guardian Pharmacy Services Acquires Assets Of Tennessee-Based Nautilus Pharmacy - TradingView
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy - Yahoo Finance
Guardian Pharmacy Surges as Earnings Beat Fuels Rally - TipRanks
Guardian Pharmacy Services Buys Assets From Nautilus Pharmacy - marketscreener.com
Guardian Pharmacy Services Buys Assets From Nautilus Pharmacy - Yahoo Finance
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy - Business Wire
Guardian (GRDN) Quarterly Figures: EPS Clears the Reported Estimate; Price Move - vinanet.vn
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 GuidanceLearn Why - simplywall.st
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 GuidanceLearn Why - simplywall.st
Guardian Pharmacy CEO to join a Sept. 15 fireside chat for investors - Stock Titan
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference - Yahoo Finance Singapore
Guardian Pharmacy Stock Sinks As IRA Fears Bite - TipRanks
GRDN Q2 2026 Earnings: EPS Beats by 21.65% as Revenue Picture Remains UnclearEPS Growth Rate - vinanet.vn
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript - AOL.com
Guardian Pharmacy Services opens first location in Kentucky - McKnight's Senior Living
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript - theglobeandmail.com
Guardian Pharmacy Services Lifts 2026 Earnings Outlook - TipRanks
Guardian Pharmacy Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
GRDN Q2 2026 Earnings: EPS of $0.34 Beats Estimates by 21.65%Profit Margin Analysis - Vinanet
GRDN Q2 2026 Earnings: 21.65% EPS Beat Overshadowed by 4.85% Stock DeclineGuidance Downgrade Alert - Vinanet
Finanzdaten der Guardian Pharmacy Services Inc-Aktie (GRDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Guardian Pharmacy Services Inc-Aktie (GRDN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morris David K | See Remarks |
Mar 20 '26 |
Sale |
29.68 |
187,855 |
5,576,006 |
254,472 |
| Burke Fred | See Remarks |
Mar 20 '26 |
Sale |
29.68 |
671,432 |
19,929,780 |
840,413 |
| Forbes Kendall | See Remarks |
Mar 20 '26 |
Sale |
29.68 |
346,672 |
10,290,092 |
453,256 |
| Cardinal Equity Fund, L.P. | Member of 10% owner group |
Mar 20 '26 |
Sale |
29.68 |
275,728 |
8,184,296 |
345,123 |
| Salentine Thomas J Jr | Director |
Mar 20 '26 |
Sale |
29.68 |
3,570,677 |
105,986,620 |
4,469,316 |
| Bindley Capital Partners I, LL | 10% Owner |
Mar 20 '26 |
Sale |
29.68 |
3,570,677 |
105,986,620 |
4,469,316 |
| Ackerman John | Director |
Mar 20 '26 |
Sale |
29.68 |
1,103,364 |
32,750,602 |
345,123 |
| BINDLEY WILLIAM E | Director |
Mar 20 '26 |
Sale |
29.68 |
3,570,677 |
105,986,620 |
4,469,316 |
| COSLER STEVEN D | Director |
Dec 03 '25 |
Buy |
29.61 |
3,370 |
99,786 |
24,984 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):